Tag
In adults with repaired Tetralogy of Fallot undergoing pulmonary valve replacement, an electrophysiology-guided ablation strategy significantly reduces ventricular tachycardia inducibility and long-term arrhythmic risk compared to empiric a
Boston Scientific slashed its 2026 sales and EPS forecasts for the second straight quarter, citing competitive pressure in pulsed field ablation and declining standalone Watchman procedures.
This phase 2 trial demonstrates that varenicline, a partial nAChR agonist, significantly reduces premature ventricular complexes and nonsustained ventricular tachycardia in post-myocardial infarction patients, offering a novel therapeutic t
The PAM-VT 2 study reveals that cardiac MRI (LGE-CMR) performed 3 to 6 months after ventricular tachycardia ablation can accurately predict long-term recurrence risks by analyzing scar stability and conducting channels.
The first-in-human VCAS trial demonstrates that high-voltage focal pulsed field ablation (PFA) safely delivers transmural lesions in thick ventricular scar tissue, significantly reducing ventricular tachycardia burden by 98% in high-risk pa
The InsightPFA trial confirms that a novel nanosecond pulsed field ablation (nsPFA) system is noninferior to radiofrequency ablation for paroxysmal atrial fibrillation, significantly reducing procedure and left atrial dwell times while main
A global Heart Rhythm Society survey reveals that 41% of EP professionals suffer from orthopedic injuries and 50% of women face pregnancy complications, highlighting the urgent need for systemic improvements in laboratory ergonomics and rad
A large-scale registry study confirms that procainamide infusion is exceptionally safe for Brugada syndrome diagnosis, with high sensitivity and specificity. Crucially, asymptomatic patients with a procainamide-induced type 1 pattern demons
Prospective cohort study reveals AV nodal versus infranodal conduction patterns underpinning timing of heart block after TAVR.
